Failure of donor irradiation and graft lymph node reduction to prolong pancreas allograft survival in cyclosporine- and donor-specific transfusion-treated hosts
Schulak, J.A.; Cooke, J.C.; Herrmann, M.J.
Transplantation 50(2): 341-343
1990
ISSN/ISBN: 0041-1337 PMID: 2382302 Document Number: 364046
Document emailed within 1 workday
Related Documents
Tchervenkov, J.I.; Epstein, M.D.; Alexander, J.W.; Schroeder, T.J. 1989: The effect of donor-specific blood transfusion, cyclosporine, and dietary prostaglandin precursors on rat cardiac allograft survival. II. Effectiveness of a 24-hour induction period with DST and CsA in inducing long-term graft survival Transplantation 47(1): 177-181Lee, T.K.; Langrehr, J.M.; Moynihan, H.L.; Stangl, M.J.; Lee, K.K.; Schraut, W.H. 1992: Failure of donor irradiation to prolong allograft survival in small bowel transplantation in rats Transplantation Proceedings 24(3): 1183-1184
Jaskłowska-Englisz, M.; Olszewski, W.L. 1994: Donor-specific transfusions prolong heart allograft survival but lymphocytes from the same donor are acutely rejected Transplantation Proceedings 26(6): 3463
Davies, C.B.; Cofer, B.R.; Alexander, J.W. 1991: Effects of donor-specific transfusion, cyclosporine a and FK 506 on rat cardiac allograft survival Transplantation Proceedings 23(6): 3314-3315
Goss, J.A.; Nakafusa, Y.; Yu, S.; Flye, M.W. 1993: Reduction in donor-specific cytotoxic T lymphocytes and prolonged cardiac allograft survival following intrathymic donor splenocyte injection Transplantation Proceedings 25(1 Part 1): 286-288
Hale, D.A.; Gottschalk, R.; Fukuzaki, T.; Wood, M.L.; Maki, T.; Monaco, A.P. 1997: Superiority of sirolimus (rapamycin) over cyclosporine in augmenting allograft and xenograft survival in mice treated with antilymphocyte serum and donor-specific bone marrow Transplantation 63(3): 359-364
Parikh, Y.; Toledo-Pereyra, L.H.; Finkelstein, I.; Bandlien, K.; Castellanos, J.; Mittal, V. 1987: Prolonged pancreas transplant survival following graft donor pretreatment with cyclosporine a or concanavalin a Transplantation Proceedings 19(5): 4336-4339
Choti, M.; Lenrow, D.; Roza, A.; Markmann, J.; Naji, A. 1989: Prolongation of cardiac allograft survival by pretransplant administration of cyclosporine and donor-specific dendritic cells Transplantation Proceedings 21(1 Pt 1): 478-479
Okazaki, H.; Takahashi, H.; Miura, K.; Ishizaki, M.; Taguchi, Y. 1984: Significant reduction of sensitization and improved allograft outcome with donor-specific buffy coat transfusion Transplantation 37(5): 523-525
Greenstein, S.M.; Sun, S.C.; Senitzer, D.; Schechner, R.S.; Tellis, V.A. 1993: Pretreatment with irradiation and donor-specific transfusion prolongs survival in small intestinal transplantation Transplantation Proceedings 25(1 Part 1): 490-491
Oluwole, S.F.; Iga, C.; Lau, H.; Hardy, M.A. 1985: Prolongation of rat heart allografts by donor-specific blood transfusion treated with ultraviolet irradiation Journal of Heart Transplantation 4(4): 385-389
Ringers, J.; Haanstra, K.G.; Kroczek, R.A.; Kliem, K.; Kuhn, E.M.; Wubben, J.; Ossevoort, M.A.; Volk, H.Dieter.; Jonker, M. 2002: Blockade of CD40-CD154 at the time of donor-specific blood transfusion does not lead to prolonged kidney allograft survival in nonhuman primates Transplantation 73(6): 862-866
Kamei, T.; Callery, M.P.; Flye, M.W. 1990: Pretransplant portal venous administration of donor antigen and portal venous allograft drainage synergistically prolong rat cardiac allograft survival Surgery 108(2): 415
Hale, D.A.; Gottschalk, R.; Fukuzaki, T.; Wood, M.L.; Maki, T.; Monaco, A.P. 1996: Extended skin allo- and xenograft survival in mice treated with rapamycin, antilymphocyte serum, and donor-specific bone marrow transfusion Transplantation Proceedings 28(6): 3269
Hillis, A.N.; Duguid, J.; Evans, C.M.; Bone, J.M.; Sells, R.A. 1987: Three year experience of donor specific transfusion and concomitant cyclosporine a Transplantation Proceedings 19(1 Part 3): 2248-2249
Farges, O.; Buffello, D.; Shi, Y.M.; Moufetier, A.; Bismuth, H. 1995: Prolongation of cardiac allograft survival following intraportal injection of donor antigen is inhibited by cyclosporine a Transplantation Proceedings 27(4): 2525-2527
Sheil, A.G.; Disney, A.P.; Mathew, T.H.; Amiss, N.; Excell, L. 1991: Cancer development in cadaveric donor renal allograft recipients treated with azathioprine (AZA) or cyclosporine (CyA) or AZA/CyA Transplantation Proceedings 23(1 Part 2): 1111-1112
Bordes-Aznar, J.; Odor, A.; Dib-Kuri, A.; Gabilondo, F.; Kasep, J.; Peña, J.C.; Herrera-Acosta, J.; Chávez-Peón, F. 1987: Randomized clinical trial of cyclosporine or donor specific transfusions in high risk living-related donor transplantation Transplantation Proceedings 19(1 Pt 3): 2276-2277
Donaldson, P.T.; Thomson, L.J.; Heads, A.; Underhill, J.A.; Vaughan, R.W.; Rolando, N.; Williams, R. 1995: IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry Transplantation 60(9): 1016-1023
Goto, M.; Yamaguchi, Y.; Matsuno, K.; Takata, N.; Makino, Y.; Kikuchi, N.; Hamaguchi, H.; Hisama, N.; Otsuka, Y.; Mori, K. 1993: Suppression of hepatic allograft rejection in the rat by mitomycin C-treated donor splenocytes: the distribution of donor class I-positive cells in the recipient Transplantation Proceedings 25(2): 1893-1895